Another update by Incannex on the NASDAQ tonight.
Potentially a very big market disruptor arriving.
RESMED should take them out soon.
Short Summary Below.
This trial is significant as it follows a successful Phase 2A study that showed a greater than 50% reduction in the apnea hypopnea index (AHI) at low doses, with 25% of patients achieving over 80% reduction.
The trial will span 52 weeks, involving 560 patients across the US, EU, and UK, and aims to provide an alternative to CPAP machines which many patients find intolerable.
www.incannex.com
- Forums
- ASX - By Stock
- RMD
- Takeover Target Potential?
Takeover Target Potential?, page-17
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$28.01 |
Change
0.265(0.96%) |
Mkt cap ! $17.43B |
Open | High | Low | Value | Volume |
$27.56 | $28.25 | $27.35 | $71.78M | 2.599M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 3734 | $28.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.01 | 1051 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1251 | 28.020 |
10 | 1143 | 28.010 |
15 | 4206 | 28.000 |
3 | 683 | 27.990 |
2 | 407 | 27.980 |
Price($) | Vol. | No. |
---|---|---|
28.050 | 1024 | 15 |
28.060 | 649 | 3 |
28.070 | 501 | 3 |
28.080 | 426 | 2 |
28.090 | 563 | 3 |
Last trade - 13.04pm 25/06/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |